Related Experiment Video
Updated: Aug 19, 2026

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
In-vitro activity of cefodizime against respiratory pathogens
R Wise1, J M Andrews, J P Ashby
1Department of Medical Microbiology, Dudley Road Hospital, Birmingham, UK.
Abstract:
The in-vitro activity of cefodizime was studied against respiratory pathogens and was compared with the activity of other beta-lactams, ciprofloxacin and erythromycin. Cefodizime displayed high activity against Haemophilus influenzae (MIC90 0.008 mg/l), Branhamella catarrhalis and Streptococcus pneumoniae (MIC90 0.5 mg/l). Klebsiella spp. were less susceptible (MIC90 2 mg/l). It was concluded that cefodizime should be a useful agent in the therapy of respiratory tract infections.
More Related Videos
Related Concept Videos
Antimicrobial Effectiveness
Microbiota of the Respiratory Tract
Mechanism of Antibiotic Resistance in MRSA

